118 related articles for article (PubMed ID: 11336112)
1. A peptide analogue of thrombin receptor-activating peptide inhibits thrombin and thrombin-receptor-activating peptide-induced vascular smooth muscle cell proliferation.
Pakala R; Liang CT; Benedict CR
J Cardiovasc Pharmacol; 2001 May; 37(5):619-29. PubMed ID: 11336112
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist.
Ahn HS; Foster C; Boykow G; Stamford A; Manna M; Graziano M
Biochem Pharmacol; 2000 Nov; 60(10):1425-34. PubMed ID: 11020444
[TBL] [Abstract][Full Text] [Related]
3. Thrombin receptor-mediated vascular relaxation differentiated by a receptor antagonist and desensitization.
Tesfamariam B
Am J Physiol; 1994 Nov; 267(5 Pt 2):H1962-7. PubMed ID: 7526715
[TBL] [Abstract][Full Text] [Related]
4. Thrombin hypothesis of thrombus generation and vascular lesion formation.
Harker LA; Hanson SR; Runge MS
Am J Cardiol; 1995 Feb; 75(6):12B-17B. PubMed ID: 7863965
[TBL] [Abstract][Full Text] [Related]
5. Indications for the presence of an atypical protease-activated receptor on rat platelets.
Ruef J; Kacharava A; Pohl J; Bode C; Runge MS
Ann Hematol; 2000 Nov; 79(11):604-11. PubMed ID: 11131919
[TBL] [Abstract][Full Text] [Related]
6. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides.
Connolly TM; Condra C; Feng DM; Cook JJ; Stranieri MT; Reilly CF; Nutt RF; Gould RJ
Thromb Haemost; 1994 Oct; 72(4):627-33. PubMed ID: 7878643
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the "tethered ligand" receptor in thrombin-induced endothelium-mediated relaxations.
Tesfamariam B; Allen GT; Normandin D; Antonaccio MJ
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1744-9. PubMed ID: 8238588
[TBL] [Abstract][Full Text] [Related]
8. Synergy between thrombin and serotonin in inducing vascular smooth muscle cell proliferation.
Pakala R; Benedict C
J Lab Clin Med; 1999 Dec; 134(6):659-67. PubMed ID: 10595795
[TBL] [Abstract][Full Text] [Related]
9. Different effects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels. Implications for venous bypass graft failure.
Yang Z; Ruschitzka F; Rabelink TJ; Noll G; Julmy F; Joch H; Gafner V; Aleksic I; Althaus U; Lüscher TF
Circulation; 1997 Apr; 95(7):1870-6. PubMed ID: 9107175
[TBL] [Abstract][Full Text] [Related]
10. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.
McNamara CA; Sarembock IJ; Gimple LW; Fenton JW; Coughlin SR; Owens GK
J Clin Invest; 1993 Jan; 91(1):94-8. PubMed ID: 8380817
[TBL] [Abstract][Full Text] [Related]
11. Hirulog-like peptide reduces balloon catheter injury induced neointima formation in rat carotid artery without increase in bleeding tendency.
Xue M; Ren S; Welch S; Shen GX
J Vasc Res; 2001; 38(2):144-52. PubMed ID: 11316950
[TBL] [Abstract][Full Text] [Related]
12. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor.
Pakala R; Liang CT; Benedict CR
Thromb Res; 2000 Oct; 100(1):89-96. PubMed ID: 11053621
[TBL] [Abstract][Full Text] [Related]
14. Thrombin receptor antagonists.
Seiler SM
Semin Thromb Hemost; 1996; 22(3):223-32. PubMed ID: 8836006
[TBL] [Abstract][Full Text] [Related]
15. Binding of a thrombin receptor tethered ligand analogue to human platelet thrombin receptor.
Ahn HS; Foster C; Boykow G; Arik L; Smith-Torhan A; Hesk D; Chatterjee M
Mol Pharmacol; 1997 Feb; 51(2):350-6. PubMed ID: 9203642
[TBL] [Abstract][Full Text] [Related]
16. Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand.
Moschonas IC; Kellici TF; Mavromoustakos T; Stathopoulos P; Tsikaris V; Magafa V; Tzakos AG; Tselepis AD
Platelets; 2017 Dec; 28(8):812-821. PubMed ID: 28267389
[TBL] [Abstract][Full Text] [Related]
17. Thrombin but not thrombin receptor activating peptide is mitogenic for coronary artery smooth muscle cells.
Bretschneider E; Wittpoth M; Weber AA; Glusa E; Schrör K
Thromb Res; 1997 Sep; 87(5):493-7. PubMed ID: 9306623
[No Abstract] [Full Text] [Related]
18. Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells.
Grinnell BW; Berg DT
Am J Physiol; 1996 Feb; 270(2 Pt 2):H603-9. PubMed ID: 8779836
[TBL] [Abstract][Full Text] [Related]
19. Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration.
Seasholtz TM; Majumdar M; Kaplan DD; Brown JH
Circ Res; 1999 May; 84(10):1186-93. PubMed ID: 10347093
[TBL] [Abstract][Full Text] [Related]
20. The cleaved peptide of PAR1 is a more potent stimulant of platelet-endothelial cell adhesion than is thrombin.
Claytor RB; Michelson AD; Li JM; Frelinger AL; Rohrer MJ; Garnette CS; Barnard MR; Krueger LA; Furman MI
J Vasc Surg; 2003 Feb; 37(2):440-5. PubMed ID: 12563219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
